Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
coral laboratories ltd. stock

CORAL LABORATORIES LTD. Share Price

774 -19.29 (-2.43%)
Nov 21 2024 03:28 PM Pharmaceuticals NSE: CORALAB

CORAL LABORATORIES LTD. Share Price Update

As of the latest trading session, CORAL LABORATORIES LTD. share price is currently at 774, which is down by -19.29 from its previous closing. Today, the stock has fluctuated between 755.05 and 810.00. Over the past year, CORAL LABORATORIES LTD. has achieved a return of 94.60 %. In the last month alone, the return has been -6.20 %. Read More...

CORAL LABORATORIES LTD. Performance

Day Range

Low755.05 High810.00
763.55

52 Week Range

Low 344.90 High 999.00
763.55

CORAL LABORATORIES LTD. Share Price

524506

CORALAB

img img img img
No Data Available

Open Price

774.00

Prev. Close

793.30

Volume (Shares)

1362.00

Total traded value

10.42

Upper Circuit

872.60

Lower Circuit

714.00

Note: The current prices & values are delayed, Login to your account for live updates.

CORAL LABORATORIES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 272.60
PE Ratio (TTM) 11.79
Book Value / Share 570.15
Beta 0.87
ROE 9.50%
EPS (TTM) 65.12
Dividend Yield 0.00%
Net Profit Qtr (Cr) 6.38

CORAL LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 32.23
Operating Expense 26.24
Net Profit 6.38
Net Profit Margin (%) 19.79
Earnings Per Share (EPS) 17.86
EBITDA 9.04
Effective Tax Rate (%) 25.20
Particulars JUN 2024 (Values in Cr)
Revenue 31.66
Operating Expense 21.44
Net Profit 8.80
Net Profit Margin (%) 27.79
Earnings Per Share (EPS) 24.64
EBITDA 12.29
Effective Tax Rate (%) 25.23
Particulars MAR 2024 (Values in Cr)
Revenue 28.89
Operating Expense 23.14
Net Profit 5.79
Net Profit Margin (%) 20.04
Earnings Per Share (EPS) 16.20
EBITDA 8.24
Effective Tax Rate (%) 25.32
Particulars DEC 2023 (Values in Cr)
Revenue 18.08
Operating Expense 16.47
Net Profit 2.16
Net Profit Margin (%) 11.94
Earnings Per Share (EPS) 6.04
EBITDA 3.46
Effective Tax Rate (%) 27.51
Particulars SEP 2023 (Values in Cr)
Revenue 23.15
Operating Expense 17.43
Net Profit 6.00
Net Profit Margin (%) 25.91
Earnings Per Share (EPS) 16.81
EBITDA 7.96
Effective Tax Rate (%) 20.21
Particulars MAR 2024 (Values in Cr)
Revenue 83.66
Operating Expense 69.40
Net Profit 15.79
Net Profit Margin (%) 18.87
Earnings Per Share (EPS) 44.19
EBITDA 22.71
Effective Tax Rate (%) 23.83
Particulars MAR 2023 (Values in Cr)
Revenue 78.12
Operating Expense 76.83
Net Profit 6.45
Net Profit Margin (%) 8.25
Earnings Per Share (EPS) 18.04
EBITDA 10.75
Effective Tax Rate (%) 21.62
Particulars MAR 2022 (Values in Cr)
Revenue 75.61
Operating Expense 69.53
Net Profit 9.05
Net Profit Margin (%) 11.96
Earnings Per Share (EPS) 25.32
EBITDA 13.99
Effective Tax Rate (%) 23.69
Particulars MAR 2021 (Values in Cr)
Revenue 96.57
Operating Expense 82.74
Net Profit 13.55
Net Profit Margin (%) 14.03
Earnings Per Share (EPS) 37.94
EBITDA 19.63
Effective Tax Rate (%) 23.05
Particulars MAR 2020 (Values in Cr)
Revenue 70.58
Operating Expense 67.36
Net Profit 7.13
Net Profit Margin (%) 10.10
Earnings Per Share (EPS) 19.96
EBITDA 11.19
Effective Tax Rate (%) 21.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share 496.83
ROE % 9.50
ROCE % 12.26
Total Debt to Total Equity 0.00
EBITDA Margin 27.15
Particulars MAR 2023 (Values in Cr)
Book Value / Share 433.29
ROE % 4.15
ROCE % 5.23
Total Debt to Total Equity 0.02
EBITDA Margin 13.76
Particulars MAR 2022 (Values in Cr)
Book Value / Share 436.81
ROE % 6.18
ROCE % 7.70
Total Debt to Total Equity 0.04
EBITDA Margin 18.50
Particulars MAR 2021 (Values in Cr)
Book Value / Share 382.48
ROE % 10.74
ROCE % 13.28
Total Debt to Total Equity 0.05
EBITDA Margin 20.34
Particulars MAR 2020 (Values in Cr)
Book Value / Share 323.77
ROE % 6.22
ROCE % 7.83
Total Debt to Total Equity 0.03
EBITDA Margin 16.02
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 61.28
Total Assets 205.68
Total Liabilities 205.68
Total Equity 177.49
Share Outstanding 3572600
Price to Book Ratio 0.75
Return on Assets (%) 7.67
Return on Capital (%) 8.9
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 40.40
Total Assets 174.34
Total Liabilities 174.34
Total Equity 154.79
Share Outstanding 3572600
Price to Book Ratio 0.53
Return on Assets (%) 3.69
Return on Capital (%) 4.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 37.47
Total Assets 189.89
Total Liabilities 189.89
Total Equity 156.05
Share Outstanding 3572600
Price to Book Ratio 0.58
Return on Assets (%) 4.76
Return on Capital (%) 5.58
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 34.82
Total Assets 167.53
Total Liabilities 167.53
Total Equity 136.64
Share Outstanding 3572600
Price to Book Ratio 0.84
Return on Assets (%) 8.09
Return on Capital (%) 9.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 29.99
Total Assets 144.28
Total Liabilities 144.28
Total Equity 115.67
Share Outstanding 3572600
Price to Book Ratio 0.30
Return on Assets (%) 4.94
Return on Capital (%) 5.86
Particulars MAR 2024 (Values in Cr)
Net Income 20.89
Cash from Operations -0.57
Cash from Investing 1.39
Cash from Financing 0.00
Net change in Cash -4.05
Free Cash Flow 0.41
Particulars MAR 2023 (Values in Cr)
Net Income 8.18
Cash from Operations 14.63
Cash from Investing -2.61
Cash from Financing -6.42
Net change in Cash 3.62
Free Cash Flow 16.57
Particulars MAR 2022 (Values in Cr)
Net Income 10.89
Cash from Operations 10.45
Cash from Investing -6.05
Cash from Financing 0.14
Net change in Cash 0.18
Free Cash Flow 16.00
Particulars MAR 2021 (Values in Cr)
Net Income 17.59
Cash from Operations 4.35
Cash from Investing -0.06
Cash from Financing 0.35
Net change in Cash 1.21
Free Cash Flow 5.71
Particulars MAR 2020 (Values in Cr)
Net Income 9.11
Cash from Operations -3.20
Cash from Investing -1.55
Cash from Financing 3.55
Net change in Cash -1.85
Free Cash Flow -1.82
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 32.10 3.04 428.00 37.54 / 77.70
BLISS GVS PHARMA LTD 120.75 15.11 1.25 1271.52 92.25 / 148.95
CIPLA LTD 1471.35 25.74 4.18 118825.56 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 331.20 115.00 3.35 974.75 145.00 / 354.60
GLAXOSMITHKLINE PHARMA LT 2436.25 51.47 24.67 41271.55 1565.05 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 48.57 9.49 428.00 37.54 / 77.70
AMRUTAJAN HEALTH LTD 720.90 43.85 6.99 2084.17 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6497.50 126.19 23.91 16243.75 4050.15 / 8139.85
BLISS GVS PHARMA LTD 120.75 15.72 1.24 1271.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 821.20
  • 26 Days 846.10
  • 10 Days 833.40
  • 50 Days 865.40
  • 12 Days 837.20
  • 100 Days 817.80
  • 20 Days 838.50
  • 200 Days 474.80
793.78
PIVOT
First Resistance 809.52
Second Resistance 825.73
Third Resistance 841.47
First Support 777.57
Second Support 761.83
Third Support 745.62
RSI 45.96
MACD -8.90
Commodity Channel Index (CCI) -121.02
ADX 14.08
Williams % R -77.07

Over 1 Month

down

-6.20

Over 3 Months

down

1.23

Over 6 Months

down

108.40

Over 1 Year

down

94.60

Over 3 Years

down

39.13

Over 5 Years

down

36.18

CORAL LABORATORIES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

CORAL LABORATORIES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
28.48
Promoter Holdings
71.51
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Chetan Navinchandra Doshi Shareholding of Promoter and Promoter Group 1841453.0 51.54
Coral India Finance And Housing Ltd Shareholding of Promoter and Promoter Group 713351.0 19.97
Meeta Samir Sheth Public Shareholding 65890.0 1.84
Pooja Bhagwandas Public Shareholding 55909.0 1.56
Noetic Finance Private Limited Public Shareholding 36820.0 1.03
Navinchandra Bachubhai Doshi Shareholding of Promoter and Promoter Group 0.0 0.0
Kundan Navinchandra Doshi Shareholding of Promoter and Promoter Group 0.0 0.0

CORAL LABORATORIES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2019-09-19 2.0 Final 2019-09-21 Equity shares 2018-09-18 2.0 Final 2018-09-21 Equity shares 2017-09-11 5.0 Final 2017-09-13 Equity shares 2016-09-16 3.0 Final 2016-09-20 Equity shares 2015-09-08 2.5 Final 2015-09-10 Equity shares 2014-09-16 2.0 Final 2014-09-18 Equity shares 2013-09-18 1.5 Final 2013-09-20 Equity shares 2012-09-17 1.5 Final 2012-09-19 Equity shares 2011-09-19 1.5 Final 2011-09-21 Equity shares 2010-09-17 1.5 Final 2010-09-21 Equity shares 2009-09-17 1.2 Final 2009-09-22 Equity shares 2008-09-19 1.0 Final 2008-09-23 Equity shares 2007-09-20 1.5 Final 2007-09-24 Equity shares 2005-09-20 0.0 Final 2005-09-22 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About CORAL LABORATORIES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by CORAL LABORATORIES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Coral Laboratories Ltd?

Answer Field

The share price of Coral Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 763.55.

What is the Market Cap of Coral Laboratories Ltd?

Answer Field

The market cap of Coral Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 2,72.60 Cr. as of now.

What is the 52 Week High and Low of Coral Laboratories Ltd?

Answer Field

The 52 Week High and Low of Coral Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 999.00 and ₹ 344.90.

How to Buy Coral Laboratories Ltd share?

Answer Field

You can trade in Coral Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Coral Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 94.60%.

What is the Current Share Price of Coral Laboratories Ltd?

Answer Field

Coral Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 763.55 as on Nov 21 2024 03:28 PM.

What is the Market Cap of Coral Laboratories Ltd Share?

Answer Field

The market cap of Coral Laboratories Ltd for NSE ₹ 0.0 & for BSE ₹ 2,72.60 as on Nov 21 2024 03:28 PM.

What is the P/E Ratio of Coral Laboratories Ltd Share?

Answer Field

As on Nov 21 2024 03:28 PM the price-to-earnings (PE) ratio for Coral Laboratories Ltd share is 11.79.

What is the PB ratio of Coral Laboratories Ltd Share?

Answer Field

As on Nov 21 2024 03:28 PM, the price-to-book (PB) ratio for Coral Laboratories Ltd share is 570.15.

How to Buy Coral Laboratories Ltd Share?

Answer Field

You can trade in Coral Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Coral Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Coral Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Coral Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader